Majzner_Lab
379 posts

Majzner_Lab
@Majzner_Lab
Robbie Majzner's Lab at Dana Farber. Focus on CAR T cell signaling & engineering, cancer immunotherapy & ganglioside biology. Interested in curing kids!



Fellowship Grant awarded to Kevin Lu of Dana-Farber Cancer Institute, mentored by Robbie Majzner and Mariella Filbin. (co-funded by the Violet Foundation for Pediatric Brain Cancer) @Majzner_Lab @FilbinMariella




Excited to support Link Cell Therapies' $60M Series A as they emerge from stealth and to partner with an outstanding syndicate led by @JNJInnovation, with participation from @samsaracapital, Sheatree Capital, @bmsnews Bristol Myers Squibb, @KyowaKirin_US, Sherpa Healthcare Partners, and other strategic investors. I first encountered Link’s groundbreaking technology when it was just a twinkle in founder @Majzner_Lab's eye at Stanford—and @Wing_VC is thrilled to support Link's pioneering work as they take this discovery to the clinic. High-fidelity AND-gated CAR-T therapies will unlock ex vivo and in vivo CAR-T efficacy for solid tumors, and the company's first lead program LNK001 aims to deliver a precise, dual-antigen approach that tackles the persistent on-target/off-tumor toxicity challenge in renal cell carcinoma (RCC). Congratulations to Robbie and co-founder Crystal Mackall, and to the entire Link Cell Therapies team! Looking forward to watching this transformative technology progress and bring hope to patients battling cancer.








Dr. @emilyliangmd expertly presenting at #ASH25 the largest study to date diving into the use of anakinra for refractory/severe ICANS (n=101). We benchmark key clinical outcomes, and identify potential predictive biomarkers of anakinra efficacy. Prospective comparative studies critically needed! #CARTx #anakinra #CARTOX @OHSUNews




